Nationwide Efficacy-Safety Study of Nebivolol in Mildly Hypertensive Patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nationwide Efficacy-Safety Study of Nebivolol in Mildly Hypertensive Patients

Published:2006-05 Issue:3 Volume:13 Page:192-197
ISSN:1075-2765
Container-title:American Journal of Therapeutics
language:en
Short-container-title:

Author:

Cleophas T. J.,Agrawal R.,Lichtenthal A.,Mäkel W.,Fici F.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology,General Medicine

Reference20 articles.

1. Nebivolol vs atenolol and placebo in essential hypertension: a double-blind randomized trial;Van Nueten;J Hum Hypertens,1998

2. A double-blind comparative trial of the effects of metoprolol and nebivolol in hypertensive patients;Van Nueten;Drug Invest,1991

3. Nebivolol versus nifedipine in the treatment of essential hypertension: a double-blind, randomized, comparative trial;Van Nueten;Am J Ther,1998

4. Nebivolol versus enalapril in the treatment of essential hypertension: a double-blind randomized trial;Van Nueten;J Hum Hypertens,1997

5. A double-blind crossover comparison of nebivolol and lisinopril in the treatment of ambulatory hypertension;Lacourci;Am J Ther,1994

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world efficacy and safety of nebivolol in Korean patients with hypertension from the BENEFIT KOREA study;Journal of Hypertension;2020-03

2. Protective effects of nebivolol from oxidative stress to prevent hypertension-related target organ damage;Journal of Human Hypertension;2017-03-02

3. Recent advances in the treatment of renal diseases with nebivolol: A literature review;Néphrologie & Thérapeutique;2016-06

4. Chronic Nebivolol Treatment Suppresses Endothelin-1–Mediated Vasoconstrictor Tone in Adults With Elevated Blood Pressure;Hypertension;2016-06

5. Hypertension treatment in the Asia-Pacific: the role of and treatment strategies with nebivolol;Heart Asia;2016-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3